BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 29376221)

  • 41. Intravitreal Delivery of VEGF-A
    Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
    Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.
    Wu YC; Chang CY; Kao A; Hsi B; Lee SH; Chen YH; Wang IJ
    PLoS One; 2015; 10(5):e0126750. PubMed ID: 25978439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy.
    McLeod DS; D'Anna SA; Lutty GA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1918-32. PubMed ID: 9727415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
    Bromberg-White JL; Boguslawski E; Hekman D; Kort E; Duesbery NS
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8979-92. PubMed ID: 21989728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy.
    Bucher F; Stahl A; Agostini HT; Martin G
    Mol Cell Neurosci; 2013 Sep; 56():225-33. PubMed ID: 23756201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
    Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Liu N; Chen L; Cai N
    Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
    Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
    Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.
    Suzuma K; Takagi H; Otani A; Oh H; Honda Y
    Am J Pathol; 1999 Feb; 154(2):343-54. PubMed ID: 10027393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease.
    Hughes S; Gardiner T; Baxter L; Chan-Ling T
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1368-79. PubMed ID: 17325186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal vascular development and oxygen-induced retinopathy: a role for adenosine.
    Lutty GA; McLeod DS
    Prog Retin Eye Res; 2003 Jan; 22(1):95-111. PubMed ID: 12597925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. R-Ras Deficiency in Pericytes Causes Frequent Microphthalmia and Perturbs Retinal Vascular Development.
    Herrera JL; Komatsu M
    J Vasc Res; 2021; 58(4):252-266. PubMed ID: 33873190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
    Akkoyun I; Karabay G; Haberal N; Dagdeviren A; Yilmaz G; Oto S; Erkanli L; Akova YA
    Acta Ophthalmol; 2012 Sep; 90(6):564-70. PubMed ID: 20698831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
    Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.
    Barnett JM; Suarez S; McCollum GW; Penn JS
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6490-8. PubMed ID: 25159209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sphingosine Kinase 2 Modulates Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    Eresch J; Stumpf M; Koch A; Vutukuri R; Ferreirós N; Schreiber Y; Schröder K; Devraj K; Popp R; Huwiler A; Hattenbach LO; Pfeilschifter J; Pfeilschifter W
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):653-661. PubMed ID: 29392309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatial distribution of CD115
    Brockmann C; Dege S; Crespo-Garcia S; Kociok N; Brockmann T; Strauß O; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):313-323. PubMed ID: 29185100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.